Bioxytran, Inc.

About Bioxytran, Inc.

Bioxytran is a clinical stage pharmaceutical company focused on developing platform technologies in Glycovirology, Hypoxia, and Degenerative Diseases to eliminate viruses and prolong lifespan through carbohydrate drug design.

Products & Services

Glycovirology Platform:A novel glycan-based platform technology using carbohydrate drugs as entry inhibitors to target viruses directly and modulate the immune system.

Hypoxia and Degenerative Diseases Platform:An innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention, targeting conditions like brain stroke, wound healing, and trauma.

ProLectin Pipeline:A pipeline focused on specific drug candidates within the Glycovirology platform.

BXT Pipeline:A pipeline of anti-necrosis drugs designed to treat hypoxia by delivering nanoscale oxygen carriers to affected tissues.

Specialties

Glycovirology Hypoxia Treatment Degenerative Diseases Carbohydrate Drug Design Oxygen Therapeutics Anti-Necrosis Drugs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 1200000 MR: - FA: 1.2 million FAN: 1200000	D: 2026-03-18 FD: 2026-03-18	-
2	RT: Stock Purchase Agreement T: - FT: Stock Purchase Agreement	A: 1600000 MR: - FA: $1,600,000 FAN: 1600000	D: 2025-01-22 FD: 2025-01-22	1 investors
3	RT: Equity T: - FT: Equity	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2023-06-12 FD: 2023-06-12	1 investors

Private Placement Latest

2026-03-18

$1.2M

Stock Purchase Agreement 2025-01-22

$1.6M

Equity 2023-06-12

$500K

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Platt

Founder

O

Ola Soderquist

CFO

D

Dr. Leslie Ajayi

CMO & Medical Advisory Board Chief

M

Mike Sheikh

Chief Communication Officier

A

Anders N. Utter

Director

A

Alan M. Hoberman

Director

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Bioxytran, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised